trial

Adapting Critical Time Intervention to Support Inpatient Medical Care Transition

NCTId NCT03637296
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Terminated
Enrollment 15 (actual)
Sponsored by New York State Psychiatric Institute, Washington Heights Community Service
Primary completion 2020-12-31
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Terminated
Enrollment
15 (actual)
Study type
Interventional
Allocation
Non Randomized
Model
Parallel
Masking
None
Start
2019-05-01
Primary completion
2020-12-31
Eligibility
ALL · 21 Years · 64 Years

Interventions & indications

Drugs
Critical time intervention

Sponsors

New York State Psychiatric Institute, Washington Heights Community ServiceLead Sponsor
HealthfirstCollaborator
Montefiore Medical CenterCollaborator
Bronx-Lebanon Hospital Center Health Care SystemCollaborator

Investigators

1
Thomas Smith, MDPrincipal Investigator

Sites

2 total
The Bronx, United StatesThe Bronx, United States

Facts & assertions

4 sourced
Enrollment
15
Phase
NA
Primary Completion Date
2020-12-31
Status
TERMINATED
relationships
The graph out of here
drug
Critical time intervention
drug
lead_sponsor
New York State Psychiatric Institute, Washington Heights Community Service
company
collaborator
Healthfirst
company
Montefiore Medical Center
company
indication
Schizophrenia
indication
Schizophrenia
indication
Medical Complication
indication
investigator
Thomas Smith, MD
person